Literature DB >> 8941633

Genetic manipulation of vascular adhesion molecules in mice.

R O Hynes1, D D Wagner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941633      PMCID: PMC507666          DOI: 10.1172/JCI119027

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

Review 1.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 2.  The biology of hematopoietic stem cells.

Authors:  S J Morrison; N Uchida; I L Weissman
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

Review 3.  Genome engineering: the new mouse genetics.

Authors:  J Rossant; A Nagy
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

Review 4.  Recent advances in gene mutagenesis by site-directed recombination.

Authors:  J D Marth
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

5.  Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins.

Authors:  P S Frenette; T N Mayadas; H Rayburn; R O Hynes; D D Wagner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

6.  Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice.

Authors:  D C Bullard; E J Kunkel; H Kubo; M J Hicks; I Lorenzo; N A Doyle; C M Doerschuk; K Ley; A L Beaudet
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  6 in total
  14 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Therapeutic inhibition of carbohydrate-protein interactions in vivo.

Authors:  J B Lowe; P A Ward
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 3.  Integrins and vascular extracellular matrix assembly.

Authors:  E Ruoslahti; E Engvall
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

4.  Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

Authors:  A Koenig; K Norgard-Sumnicht; R Linhardt; A Varki
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 5.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

6.  β4 integrin marks interstitial myogenic progenitor cells in adult murine skeletal muscle.

Authors:  Kalliopi Liadaki; Juan Carlos Casar; McKenzie Wessen; Eric S Luth; Susan Jun; Emanuela Gussoni; Louis M Kunkel
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

7.  A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation.

Authors:  M J Cotter; K E Norman; P G Hellewell; V C Ridger
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

8.  Vitamin D receptor signaling inhibits atherosclerosis in mice.

Authors:  Frances L Szeto; Catherine A Reardon; Dosuk Yoon; Youli Wang; Kari E Wong; Yunzi Chen; Juan Kong; Shu Q Liu; Ravi Thadhani; Godfrey S Getz; Yan Chun Li
Journal:  Mol Endocrinol       Date:  2012-05-25

9.  P-selectin deficiency attenuates tumor growth and metastasis.

Authors:  Y J Kim; L Borsig; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.